Friday September 18, 2:09 pm Eastern Time
Company Press Release
Alta Natural: HEPATICO Tests Expanded After Positive Results, TSE
and NASDAQ Listings Sought
RICHMOND, B.C.- (BW HealthWire) - Sept. 18, 1998
Alta Natural (Alberta Stock Exchange:AHS. - news) Initial results
from HEPATICO give optimism to millions suffering from Hep-C.
Company President, Adolph Huckschlag, reports that the Company
is beginning to receive preliminary results from the testing of its
Hepatitis-C treatment, HEPATICO. ``The test results, which have
been reviewed by Dr. David Khoupenia, Alta Natural's Medical
Co-ordinator, are very encouraging'' according to Huckschlag.
``Our results are generally supporting the conclusions of the 17
clinical and pre-clinical trials done in Europe that HEPATICO is
effective in normalizing human liver function in Hepatitis-C
sufferers,'' said Dr. Khoupenia. ``We have documented substantial
declines in liver enzyme counts in as little as 45 days of
treatment with HEPATICO. Some participants have seen their Liver
Function Test scores return to normal levels within 30 days. In
addition, nearly all the patients are reporting decreased fatigue
and an increased sense of well being; a sign that liver function is
beginning to return to normal.''
Commenting on the timing of the balance of the preliminary data
Huckschlag said, ``We expect the majority of our initial results to
be in within the next two weeks''.
Once Dr. David Khoupenia has had the opportunity to analyze and
compare test results, the Company will announce their findings
along with English-translated copies of the 17 previous trials at a
press conference to be announced in early October of this year.
Due to overwhelming demand from Hepatitis-C sufferers from
around the world, Alta Natural's President announced that the
Company will immediately expand its HEPATICO tests beyond the
current 100 participant limit. Sufferers interested in
participating should contact the Company. Participants are required
to have full blood workings completed prior to starting the
treatment as well as the knowledge and support of their general
practitioner.
Following up on its commitment to shareholders, Alta Natural has
begun the process to list for trading on the Toronto Stock Exchange
and the NASDAQ Bulletin Board. The Company expects to complete
these listings within the next six to nine months. Adolph
Huckschlag, President
The Alberta Stock Exchange has neither approved nor disapproved
of the contents of this Press Release.
Contact:
The Capitalists Capital Corp. Investment Information
800/969-7222 or 604/689-0087
or
Alta Natural Herbs & Supplements Ltd.,
604/303-1131 or 1-800-535-7502
604/303-1132 (FAX)
email: altanat@axionet.com
website: http://www.alta-natural.com
Read more about
Hepatico:
Alta
Natural: Hepatico Results In; Hepatitis-C Sufferers Benefit from
Naturopathic Treatment
HEPATICO
trials
Home | What is HCV | Transmission |
Future |
Complications |
Biopsy |
Treatment
| Lab |
Nutrition |
Patient |
Links | Transplant |
Webrings |
guestbookbook |
Awards |
FAQ
|